Linkedin
Sign in
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Type here...
Search
Home
About
Editor’s Corner
Contribute
Contact Us
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
Solutions & Pricing
Partner
Instagram
Linkedin
Twitter
Subscribe
Subscribe
Saturday, April 25, 2026
33.6
C
Bengaluru
Home
About
Editor’s Corner
Contribute
Contact Us
My account
Get into your account.
Login
Register
type here...
Search
Facebook
Linkedin
Twitter
Youtube
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Hot topics
Indian Pharma October 2025 Sales Data
0
1. Overall Market Growth & Trends (IPM Key Highlights): Robust...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Creat Customer
0
Articles by K. Hariram, Hanno Wolfram, Vivek Hattangadi, Salil Kallianpur, Amit Jain, Dr. Palakodeti Ratnakar, and Pankaj Mehrotra
Not Digital Solutions alone, but Business Solutions that add Value to Customers delivered via Digital Platforms
0
Yesterday I received a WhatsApp from a famous shoe...
Astra Zeneca Tops Indian Pharma in New Introductions 2024
0
Analysis of Indian Pharmaceutical Market (IPM) – 2024 This data...
Facebook
Linkedin
Twitter
Youtube
Healthcare Trends
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
0
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
0
Ritesh Desai has joined Standard Chartered India as Executive...
Marketing
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
0
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
0
Ritesh Desai has joined Standard Chartered India as Executive...
Policies/Sales
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
0
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
0
Ritesh Desai has joined Standard Chartered India as Executive...
Strategy
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
0
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
0
Ritesh Desai has joined Standard Chartered India as Executive...
Subscribe
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Hot topics
Frontline Managers
0
Articles by Vivek Hattangadi, Raja Reddy, K. Hariram, Satish Kota, P. S. Parameswaran, Gopal Kishore, Ramandish Arora, Mohit Kumar Bhutani, Richa Goyal and Mahendra Kumar Rai
Quality, Not Price: Why the Generic Drug Debate Keeps Missing the Point
0
In an earlier article in The Wire Science, I...
Nutraceuticals: Health, Hope Or Hype?
0
Walk into almost any clinic today and you will...
IPM November 2025 Sales Data Analysis
0
IPM Momentum, Innovation Waves & the AQI-Driven Respiratory Surge...
Culture and Resistance to Change – A Pharma SFE Adoption Case Study
0
As an MNC Head, I was one among the...
Facebook
Linkedin
Twitter
Youtube
Healthcare Trends
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
0
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
0
Ritesh Desai has joined Standard Chartered India as Executive...
Marketing
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
0
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
0
Ritesh Desai has joined Standard Chartered India as Executive...
Policies/Sales
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
0
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
0
Ritesh Desai has joined Standard Chartered India as Executive...
Strategy
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
0
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
0
Ritesh Desai has joined Standard Chartered India as Executive...
Subscribe
Screen Shot 2016-02-07 at 6.04.49 pm